ROG.SW vs. ABBV
Compare and contrast key facts about Roche Holding AG (ROG.SW) and AbbVie Inc. (ABBV).
Performance
ROG.SW vs. ABBV - Performance Comparison
Loading graphics...
ROG.SW vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ROG.SW Roche Holding AG | -2.03% | 32.70% | 8.83% | -12.71% | -21.33% | 26.38% | 1.56% | 33.13% | 2.47% | 9.46% |
ABBV AbbVie Inc. | -3.51% | 16.28% | 28.23% | -9.17% | 25.71% | 36.33% | 16.95% | -0.26% | 0.01% | 53.28% |
Different Trading Currencies
ROG.SW is traded in CHF, while ABBV is traded in USD. To make them comparable, the ABBV values have been converted to CHF using the latest available exchange rates.
Returns By Period
In the year-to-date period, ROG.SW achieves a -2.03% return, which is significantly higher than ABBV's -3.51% return. Over the past 10 years, ROG.SW has underperformed ABBV with an annualized return of 6.30%, while ABBV has yielded a comparatively higher 16.91% annualized return.
ROG.SW
- 1D
- 2.03%
- 1M
- -12.38%
- YTD
- -2.03%
- 6M
- 23.72%
- 1Y
- 10.69%
- 3Y*
- 10.22%
- 5Y*
- 3.94%
- 10Y*
- 6.30%
ABBV
- 1D
- 1.96%
- 1M
- -2.70%
- YTD
- -3.51%
- 6M
- -4.33%
- 1Y
- -3.21%
- 3Y*
- 9.86%
- 5Y*
- 15.50%
- 10Y*
- 16.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ROG.SW vs. ABBV — Risk / Return Rank
ROG.SW
ABBV
ROG.SW vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Roche Holding AG (ROG.SW) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ROG.SW | ABBV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.35 | -0.11 | +0.46 |
Sortino ratioReturn per unit of downside risk | 0.67 | 0.04 | +0.62 |
Omega ratioGain probability vs. loss probability | 1.09 | 1.01 | +0.08 |
Calmar ratioReturn relative to maximum drawdown | 0.40 | -0.03 | +0.43 |
Martin ratioReturn relative to average drawdown | 0.83 | -0.06 | +0.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ROG.SW | ABBV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.35 | -0.11 | +0.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.20 | 0.66 | -0.46 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | 0.63 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.65 | -0.28 |
Correlation
The correlation between ROG.SW and ABBV is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ROG.SW vs. ABBV - Dividend Comparison
ROG.SW's dividend yield for the trailing twelve months is around 3.14%, more than ABBV's 3.06% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROG.SW Roche Holding AG | 3.14% | 2.96% | 3.76% | 3.89% | 3.20% | 2.40% | 2.91% | 2.77% | 3.41% | 3.33% | 3.48% | 2.89% |
ABBV AbbVie Inc. | 3.06% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
Drawdowns
ROG.SW vs. ABBV - Drawdown Comparison
The maximum ROG.SW drawdown since its inception was -58.88%, which is greater than ABBV's maximum drawdown of -42.55%. Use the drawdown chart below to compare losses from any high point for ROG.SW and ABBV.
Loading graphics...
Drawdown Indicators
| ROG.SW | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.88% | -45.09% | -13.79% |
Max Drawdown (1Y)Largest decline over 1 year | -19.49% | -16.74% | -2.75% |
Max Drawdown (5Y)Largest decline over 5 years | -42.26% | -21.92% | -20.34% |
Max Drawdown (10Y)Largest decline over 10 years | -42.26% | -45.09% | +2.83% |
Current DrawdownCurrent decline from peak | -14.02% | -9.64% | -4.38% |
Average DrawdownAverage peak-to-trough decline | -16.06% | -10.70% | -5.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.22% | 8.12% | +2.10% |
Volatility
ROG.SW vs. ABBV - Volatility Comparison
Roche Holding AG (ROG.SW) and AbbVie Inc. (ABBV) have volatilities of 7.22% and 6.88%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ROG.SW | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.22% | 6.88% | +0.34% |
Volatility (6M)Calculated over the trailing 6-month period | 18.25% | 18.70% | -0.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.29% | 29.01% | -3.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.07% | 23.67% | -3.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.70% | 26.75% | -7.05% |
Financials
ROG.SW vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Roche Holding AG and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities